Category: Science


Putting Healthy Skin First - L’Oréal Active Cosmetics Division & MRA Strengthen Longstanding L’Oréal and MRA Partnership

By Cody R. Barnett, MRA Director of Communications | 1 May 2020 In Allies & Partnerships, News, Science

Some partnerships just make sense. For example, L’Oréal-owned SkinCeuticals, CeraVe and La Roche-Posay apart of the L’Oreal Active Cosmetics Division and MRA both share a mission and ethos for promoting healthy skin. It is no surprise that the two are longtime partners in the fight against melanoma. In fact, these brands and MRA have just announced an expanded partnership just in time for Melanoma Awareness Month.

Read More


MRA Announces $11 Million for 26 Grant Awards to Advance Melanoma Research

By Cody R. Barnett, MRA Director of Communications | 30 April 2020 In News, Science

With the world’s attention focused on the response to COVID-19, the Melanoma Research Alliance (MRA) knows that long after this pandemic has ended, melanoma research will still be urgently needed. To this end, and in recognition of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, is proud to announce funding for 26 research awards totaling $10.9 million.

Read More


Bridging the Knowledge Gap Through AI

30 April 2020 In Science

Meet Enrica Quattrocchi, a clinical dermatology fellow at the Mayo Clinic, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.

Read More


Dr. Villanueva Takes Aim at NRAS Mutant Melanoma

By Cody R. Barnett, MRA Director of Communications | 28 March 2020 In Melanoma Stories, Science, Treatment

When Dr. Villanueva began her work in melanoma, some 15 years ago, it was the perfect scientific challenge. How could a disease be so aggressive – and still be such a mystery?
Then things got personal.

Read More


Coronavirus: What People with Cancer Should Know

24 March 2020 In News, Policy, Science, Treatment

Coronaviruses are a large family of viruses that are common in people and many different species of animals. CDC is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China and has now been detected in the United States and many other countries.

Read More


Harnessing Artificial Intelligence to Detect Melanoma Earlier

2 March 2020 In Science

As an internist, Dr. Joann Elmore was taught to ask questions. Those questions led her to spend much of her career in breast cancer research where she found extensive variability among radiologists’ interpretation of mammograms. “Radiology data is subjective, just like art. You’re being asked to classify visual data,” Elmore says.

Read More


Combination Therapy: Why Timing Might Be Everything

By Rachel Fischer, Ph.D., Senior Associate, Scientific Program and Grants Administration | 13 February 2020 In Science

About half of all melanomas have a mutated BRAF gene. This mutated gene makes an altered BRAF protein, which leads to the uncontrolled growth of melanoma cells. Drugs targeting these altered BRAF proteins, such as Vemurafenib and Dabrafenib have been approved for the treatment of BRAF+ melanoma.

Read More


Clinical Trials to Watch: Intralesional Therapies for Melanoma

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 8 February 2020 In Science, Treatment

To an outsider, the number of new treatment options for melanoma may seem to be moving at a breakneck pace. Checkpoint immunotherapy and BRAF/MEK inhibitors have greatly improved outcomes for many late-stage melanoma patients, with over 50% of patients on combination ipilimumab/nivolumab still alive after 5 years.

Read More


Stage 4 Melanoma, a Vaccine Clinical Trial, and the Power of Family & Faith

By Cody R. Barnett, MRA Director of Communications | 7 February 2020 In Melanoma Stories, Science, Treatment

“Clinical trials allow you to take advantage of the latest research and experiences from doctors and patients who’re blazing the trails. Clinical trials are also a way for you to help the next person who is going to have to go through this. If you have the opportunity to be part of something that helps others, why wouldn’t you at least try it?”

Read More


Melanoma Research Advances – 2019 in Review

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 27 January 2020 In Policy, Prevention, Science, Treatment

During 2019, melanoma research continued its rapid pace of advancement, with FDA approval of a new adjuvant therapy treatment option, several first-in-human clinical trials, and significant progress towards earlier intervention.

Read More


Login

×